PMID: 7017686Jan 1, 1980Paper

Less aggressive rejection therapy and low-dose corticosteroids leading to satisfactory cadaveric kidney graft survival and low morbidity rate

Proceedings of the European Dialysis and Transplant Association
J P van HooffJ de Graeff

Abstract

A less aggressive approach in treatment of rejection crises has been introduced since January 1979. Findings in 39 patients demonstrate that rejection treatment can be started later and be applied with considerably less frequency without an increase in graft loss. A reduction of more than 50% in corticosteroid dosage applied within three months after transplantation seems to be possible, with a sharp decrease of morbidity rate.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Revue européenne d'études cliniques et biologiques. European journal of clinical and biological research
J F Bach, M Leski
Khirurgiia
O S BelorusovN T Vorob'eva
Connecticut Medicine
R U Massey
Vestnik Rossiĭskoĭ akademii meditsinskikh nauk
M Ia RatnerN D Fedorova
© 2021 Meta ULC. All rights reserved